Dépôt numérique

Interferon regulatory factor 5 expression in myeloid cells and T cells negatively impacts the outcome of visceral leishmaniasis

Mai, Linh Thuy; Fabié, Aymeric; Smans, Mélina; Hammami, Akil et Stäger, Simona ORCID logoORCID: https://orcid.org/0000-0001-5508-9565 (2020). Interferon regulatory factor 5 expression in myeloid cells and T cells negatively impacts the outcome of visceral leishmaniasis In: Annual Meeting of the American-Association-of-Immunologists - Immunology 2020, annulé, Honolulu, HI.

Ce document n'est pas hébergé sur EspaceINRS.


Visceral leishmaniasis (VL) is a potentially fatal disease caused by Leishmania donovani and/or L. infantum. VL is characterized by hepatosplenomegaly, immune suppression, and chronic inflammation. We have previously reported that the transcription factor IRF-5 largely contributes to the induction of inflammation and the development of splenomegaly in mice infected with L. donovani. Moreover, Irf5−/− mice only develop limited IFNγ+ CD4 T responses and are more susceptible to infection. However, the cellular source of IRF-5 responsible for these effects is yet unknown. IRF-5 is constitutively expressed in several cells, such as macrophages, B cells, and dendritic cells. We have recently reported that CD4 T cells also express IRF-5 during chronic VL. Here, we investigate IRF-5 function in myeloid and CD4 T cells during VL, using cell-specific knockout mice. First, we show that IRF-5 expression in CD11c+ cells is required for the generation of splenomegaly and leads to increased disease susceptibility. We also demonstrate that IRF-5 expression in CD11c+ cells is not crucial for the development of Th1 responses. Moreover, we demonstrate that IRF-5 activation in Th1 cells results in cell death during chronic L. donovani infection. Triggering of TLR7 by apoptotic cell material promotes IRF-5 activation in Th1 cells. This results in the upregulation of death receptor 5 and caspase 8, making IFNγ+ CD4 T cells more prone to cell death. Because chronic inflammation and tissue disruption are common characteristics of persistent infections, the TLR7- IRF-5 pathway in CD4 T cells may represent a novel mechanism aimed at protecting tissues against sustained inflammation.

Type de document: Document issu d'une conférence ou d'un atelier
Informations complémentaires: Affiche scientifique P811 Journal of Immunology 204 (suppl. 1) S156.13
Mots-clés libres: =
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 23 juin 2022 02:33
Dernière modification: 23 juin 2022 02:33
URI: https://espace.inrs.ca/id/eprint/12377

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice